Studies related to Breast Tenderness and Serrapeptase

The Treatment Of Breast Engorgement With Serrapeptase (Danzen): A Randomised Double-blind Controlled Trial

Effect Decrease
Trial Design Double blind
Trial Length 1-7 Days
Number of Subjects 70
Sex Female
Age Range 18-29, 30-44
Body Types Average
Notes for this study:
10mg serrapeptase thrice daily (30mg total) for 3 days in women with breast engorgement was able to reduce pain and tenderness as assessed by self-report surveys.